Related Experiment Video
Updated: Jun 26, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Arginine methylation of caspase-8 controls life/death decisions in extrinsic apoptotic networks
Fabian Wohlfromm1, Nikita V Ivanisenko1, Sabine Pietkiewicz1
1Translational Inflammation Research, Medical Faculty, Center of Dynamic Systems (CDS), Otto von Guericke University, 39106, Magdeburg, Germany.
Abstract:
Procaspase-8 is a key mediator of death receptor (DR)-mediated pathways. Recently, the role of post-translational modifications (PTMs) of procaspase-8 in controlling cell death has received increasing attention. Here, using mass spectrometry screening, pharmacological inhibition and biochemical assays, we show that procaspase-8 can be targeted by the PRMT5/RIOK1/WD45 methylosome complex. Furthermore, two potential methylation sites of PRMT5 on procaspase-8, R233 and R435, were identified in silico. R233 and R435 are highly conserved in mammals and their point mutations are among the most common mutations of caspase-8 in cancer. The introduction of mutations at these positions resulted in inhibitory effects on CD95L-induced caspase-8 activity, effector caspase activation and apoptosis. In addition, we show that procaspase-8 can undergo symmetric di-methylation. Finally, the pharmacological inhibition of PRMT5 resulted in the inhibitory effects on caspase activity and apoptotic cell death. Taken together, we have unraveled the additional control checkpoint in procaspase-8 activation and the arginine methylation network in the extrinsic apoptosis pathway.
Insights
Procaspase-8, a key player in cell death, is regulated by arginine methylation. This study identifies PRMT5 as a methyltransferase targeting procaspase-8, impacting apoptosis and cancer-associated mutations.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Procaspase-8 is central to death receptor-mediated apoptosis.
- Post-translational modifications (PTMs) of procaspase-8 are increasingly recognized for their role in regulating cell death.
- Understanding procaspase-8 regulation is crucial for cancer research.
Purpose of the Study:
- To investigate the role of post-translational modifications in procaspase-8 activation.
- To identify specific enzymes and sites involved in procaspase-8 modification.
- To explore the functional consequences of these modifications on apoptosis and cancer.
Main Methods:
- Mass spectrometry screening to identify potential modifications.
- Pharmacological inhibition of key enzymes.
- Biochemical assays to assess enzyme activity and protein interactions.
- In silico identification of potential methylation sites.
- Site-directed mutagenesis to study the effects of specific mutations.
Main Results:
- Procaspase-8 is targeted by the PRMT5/RIOK1/WD45 methylosome complex.
- Two key arginine residues (R233 and R435) on procaspase-8 were identified as potential PRMT5 methylation sites.
- Mutations at R233 and R435 inhibited CD95L-induced caspase-8 activity, effector caspase activation, and apoptosis.
- Procaspase-8 can undergo symmetric di-methylation.
- Pharmacological inhibition of PRMT5 reduced caspase activity and apoptotic cell death.
Conclusions:
- Arginine methylation by the PRMT5 complex represents a novel regulatory checkpoint for procaspase-8 activation.
- The identified methylation sites are conserved and their mutations are relevant to cancer.
- This work elucidates an arginine methylation network in extrinsic apoptosis, offering potential therapeutic targets.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

